Mast cells and eosinophils in invasive breast carcinoma

被引:66
作者
Amini, Rose-Marie [1 ]
Aaltonen, Kirsimari
Nevanlinna, Heli
Carvalho, Ricardo
Salonen, Laura
Heikkila, Paivi
Blomqvist, Carl
机构
[1] Univ Uppsala Hosp, Dept Genet & Pathol, Uppsala, Sweden
[2] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland
[4] Karolinska Inst, Dept Med, Stockholm, Sweden
[5] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland
[6] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
关键词
D O I
10.1186/1471-2407-7-165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Inflammatory cells in the tumour stroma has gained increasing interest recently. Thus, we aimed to study the frequency and prognostic impact of stromal mast cells and tumour infiltrating eosinophils in invasive breast carcinomas. Methods: Tissue microarrays containing 234 cases of invasive breast cancer were prepared and analysed for the presence of stromal mast cells and eosinophils. Tumour infiltrating eosinophils were counted on hematoxylin-eosin slides. Immunostaining for tryptase was done and the total number of mast cells were counted and correlated to the proliferation marker Ki 67, positivity for estrogen and progesterone receptors, clinical parameters and clinical outcome. Results: Stromal mast cells were found to correlate to low grade tumours and estrogen receptor positivity. There was a total lack of eosinophils in breast cancer tumours. Conclusion: A high number of mast cells in the tumours correlated to low-grade tumours and estrogen receptor positivity. Eosinophils are not tumour infiltrating in breast cancers.
引用
收藏
页数:5
相关论文
共 36 条
  • [1] AALTOMAA S, 1993, ANTICANCER RES, V13, P785
  • [2] Almholt K, 2003, RECENT RESULTS CANC, V162, P31
  • [3] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [4] The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix
    Benítez-Bribiesca, L
    Wong, A
    Utrera, D
    Castellanos, E
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (08) : 1061 - 1062
  • [5] BOWERS HM, 1979, CANCER, V43, P568, DOI 10.1002/1097-0142(197902)43:2<568::AID-CNCR2820430225>3.0.CO
  • [6] 2-#
  • [7] Inflammatory cells and cancer: Think different!
    Coussens, LM
    Werb, Z
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (06) : F23 - F26
  • [8] The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis
    Dabiri, S
    Huntsman, D
    Makretsov, N
    Cheang, M
    Gilks, B
    Bajdik, C
    Gelmon, K
    Chia, S
    Hayes, M
    [J]. MODERN PATHOLOGY, 2004, 17 (06) : 690 - 695
  • [9] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
    Dave, SS
    Wright, G
    Tan, B
    Rosenwald, A
    Gascoyne, RD
    Chan, WC
    Fisher, RI
    Braziel, RM
    Rimsza, LM
    Grogan, TM
    Miller, TP
    LeBlanc, M
    Greiner, TC
    Weisenburger, DD
    Lynch, JC
    Vose, J
    Armitage, JO
    Smeland, EB
    Kvaloy, S
    Holte, H
    Delabie, J
    Connors, JM
    Lansdorp, PM
    Ouyang, Q
    Lister, TA
    Davies, AJ
    Norton, AJ
    Muller-Hermelink, HK
    Ott, G
    Campo, E
    Montserrat, E
    Wilson, WH
    Jaffe, ES
    Simon, R
    Yang, LM
    Powell, J
    Zhao, H
    Goldschmidt, N
    Chiorazzi, M
    Staudt, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) : 2159 - 2169
  • [10] Paradoxical roles of the immune system during cancer development
    de Visser, KE
    Eichten, A
    Coussens, LM
    [J]. NATURE REVIEWS CANCER, 2006, 6 (01) : 24 - 37